Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Creative Diagnostics Launches Recombinant HPV L1 VLP for Science Research

Creative Diagnostics
Posted on: 17 Sep 18

As a leader in the manufacture of raw materials, reagents and antibodies for biotechnology industry, Creative Diagnostics now establishes a global-leading virus-like particles (VLPs) manufacture platform using E. coli cell system, and launches varieties of Recombinant HPV L1 VLP products to the global life science researchers. These HPV VLPs products are contributed to the HPV vaccine related research, and can also be typically used for antibody discovery, vaccine or diagnostic reagent development, and protein-based assays, e.g. ELISA.

Human papillomavirus (HPV) is a DNA virus from the papillomavirus family that is capable of infecting humans. Like all papillomaviruses, HPVs establish productive infections only in keratinocytes of the skin or mucous membranes. There are two virus capsid proteins L1 and L2; L1 is a major capsid protein of human papilloma virus. Infection with specific types of HPV has been associated with an increased risk of developing cervical neoplasia.  

Human papillomavirus associated cancers include those of the cervix, vulva, vagina, penis, anus, rectum and oropharynx. Because over 80% of all HPV associated cancers occur in the cervix, nearly all of the evidence for prophylactic vaccine prevention of incident type specific HPV infection are in cervical disease. 

"With years of exploration, our scientists have successfully obtained various highly purified HPV VLPs. HPV L1 Antibodies for Neutralization and Vaccine Development are one of our featured products. Creative Diagnostics provides unique and innovative tools for researchers and we would like to provide support and interact directly with life science researchers or companies in the USA as well as worldwide.  Our experience will be of great value to them considering the increasing need of the clients." said one of a senior scientific officer of R&D department of Creative Diagnostics.

"Our team are always focused on providing the right products and solutions for researchers wishing to partner with us. Creative Diagnostics also brings a wealth of experience that will be of immense benefit to our clients. We look forward to working with our clients to ensure they have the best outcome when it comes to their research projects." said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.

If you want to know more information about the Recombinant HPV L1 VLP, please contact Creative Diagnostics at 1-631-619-7922 or email to contact@creative-diagnostics.com.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers’ assay development and manufacturing needs.

For more information:
www.creative-diagnostics.com/news-recombinant-hpv-l1-vlp-68.htm

Editor's Details

Thomas Schmitt
Creative Diagnostics
www.creative-diagnostics.com
16316197922
contact@creative-diagnostics.com

Last updated on: 17/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.